Related Experiment Video
Updated: Oct 12, 2025

Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route
Published on: May 31, 2022
Differential Stimulation of Pluripotent Stem Cell-Derived Human Microglia Leads to Exosomal Proteomic Changes
Anna Mallach1, Johan Gobom2,3, Charles Arber4
1Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College, London WC1N 1PJ, UK.
Abstract:
Microglial exosomes are an emerging communication pathway, implicated in fulfilling homeostatic microglial functions and transmitting neurodegenerative signals. Gene variants of triggering receptor expressed on myeloid cells-2 (TREM2) are associated with an increased risk of developing dementia. We investigated the influence of the TREM2 Alzheimer's disease risk variant, R47Hhet, on the microglial exosomal proteome consisting of 3019 proteins secreted from human iPS-derived microglia (iPS-Mg). Exosomal protein content changed according to how the iPS-Mg were stimulated. Thus lipopolysaccharide (LPS) induced microglial exosomes to contain more inflammatory signals, whilst stimulation with the TREM2 ligand phosphatidylserine (PS+) increased metabolic signals within the microglial exosomes. We tested the effect of these exosomes on neurons and found that the exosomal protein changes were functionally relevant and influenced downstream functions in both neurons and microglia. Exosomes from R47Hhet iPS-Mg contained disease-associated microglial (DAM) signature proteins and were less able to promote the outgrowth of neuronal processes and increase mitochondrial metabolism in neurons compared with exosomes from the common TREM2 variant iPS-Mg. Taken together, these data highlight the importance of microglial exosomes in fulfilling microglial functions. Additionally, variations in the exosomal proteome influenced by the R47Hhet TREM2 variant may underlie the increased risk of Alzheimer's disease associated with this variant.
Insights
The Alzheimer's disease risk variant R47H in TREM2 alters microglial exosomes, impacting neuronal function and potentially increasing dementia risk. These exosomes carry disease-associated proteins, affecting neuronal growth and metabolism.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Microglial exosomes mediate cell communication, influencing both homeostasis and neurodegeneration.
- Genetic variants in triggering receptor expressed on myeloid cells-2 (TREM2) are linked to increased dementia risk.
Purpose of the Study:
- To investigate how the TREM2 Alzheimer's disease risk variant (R47Hhet) affects the proteome of microglial exosomes.
- To determine the functional consequences of these exosomal changes on neuronal and microglial cells.
Main Methods:
- Proteomic analysis of exosomes secreted from human induced pluripotent stem cell-derived microglia (iPS-Mg) with the R47Hhet TREM2 variant.
- Stimulation of iPS-Mg with lipopolysaccharide (LPS) and phosphatidylserine (PS+) to observe changes in exosomal protein content.
- Functional assays assessing the impact of exosomes on neuronal process outgrowth and mitochondrial metabolism.
Main Results:
- Exosomal protein content varied with stimulation; LPS increased inflammatory signals, while PS+ increased metabolic signals.
- Exosomes from R47Hhet iPS-Mg contained disease-associated microglial (DAM) signature proteins.
- Exosomes from R47Hhet iPS-Mg impaired neuronal process outgrowth and reduced mitochondrial metabolism in neurons compared to exosomes from common TREM2 variant iPS-Mg.
Conclusions:
- Microglial exosomes play a crucial role in microglial functions and intercellular communication.
- Alterations in the exosomal proteome due to the R47Hhet TREM2 variant may contribute to the heightened risk of Alzheimer's disease.
More Related Videos
11:19Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes
Published on: August 18, 2022
06:12Author Spotlight: Induced Microglia-Like Cell Technology to Shed Light on the Role of Microglial Dysfunction in Neuropsychiatric Disorders
Published on: September 6, 2024